The prokinetic agents in this class include bethanechol, which was used to treat heartburn and gastroparesis, a condition that causes partial paralysis in your stomach.

Most of the available prokinetic drugs have multiple actions, targeting both sensory and motor pathways, and the agents providing greatest symptom relief are not necessarily the most potent in ...

Discussion . To date, six other meta-analyses of prokinetic agents for treatment of FD have been reported ( Table 2). [43,44,45,46,47,48] In terms of the agents investigated and the scope of the ...

Methods Selection of Studies. Studies on prokinetic agents, including metoclopramide, domperidone, trimebutine, cisapride, itopride and mosapride, in patients with FD were identified by ...

Medically reviewed by Lindsay Cook, PharmD Several available over-the-counter (OTC) and prescription drugs can help manage ...

Prokinetic agents produce an increase in LES tone, which, along with acid suppression, plays a key role in bringing reflux under control. Cisapride, ...

TZP-102 is a novel, orally administered prokinetic agent that acts by a mechanism distinct from previously developed products for gastrointestinal (GI) motility disorders. TZP-102 is a ...

Many common drugs, including some prokinetic, antibiotic and anti-psychotic medications, can change how the heart’s electrical system functions. This is known as QT-prolongation, ...

TOKYO, Mar 14, 2018 - (JCN Newswire) - Eisai Co., Ltd. announced today that its Chinese subsidiary Eisai China Inc. has launched the gastrointestinal prokinetic agent Cidine in China.Cidine is a ...